by Cells4Life Middle East | Aug 20, 2018 | Stem Cell News
When Pat Wilkinson was fitted with a pacemaker, he was told he had a 50% chance of being alive in five year’s time. The 80 years old retiree had suffered from heart failure and required a pacemaker to keep his heartbeat regular. Fast forward 15-years and...
by Cells4Life Middle East | Aug 17, 2018 | Stem Cell News
A new cord-blood technology developed by Canadian researchers has just passed a key milestone and will now move onto Phase I/II clinical trials. The technology multiplies the number of cord blood stem cells that can be obtained from a cord blood sample, allowing...
by Cells4Life Middle East | Aug 13, 2018 | Stem Cell News
Scientists in the United States are about to commence a five year, Phase II clinical trial using stem cells to treat lupus. It is a ground breaking trial supported by the Lupus Foundation of America and the National Institute of Allergy and...
by Cells4Life Middle East | Aug 10, 2018 | Stem Cell News
New details of a stem cell clinical trial for severe blood cancers have just been announced by biotechnology company ExCellThera. ExCellThera is a large company that specialises in bioengineering solutions to expand blood stem cells before transplantation. The...
by Cells4Life Middle East | Aug 6, 2018 | Stem Cell News
An American research team has developed an exciting new technology that uses stem cells to engineer large bone segments. The team, from the New York Stem Cell Foundation (NYSCF), calls the method Segmental Additive Tissue Engineering (SATE). SATE allows doctors...
